<DOC>
	<DOCNO>NCT02860845</DOCNO>
	<brief_summary>The purpose study determine whether formula boric acid probiotic vaginal application effective treatment symptomatic episode vulvovaginitis comparison pharmacological reference control ( depend suspect diagnosis ) .</brief_summary>
	<brief_title>Use Boric Acid Combination With Probiotics Treatment Vaginal Infections</brief_title>
	<detailed_description>Multicentre , Open , Prospective , Randomized , Controlled . Women suspect vaginal infection randomize distribute two group ( control boric acid + probiotic ) . Follow-up last three month consist 3 visit telephone interview .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<criteria>Age 18 year agreement participate signing consent form . Women clinical manifestation acute infectious vulvovaginitis ( burning , pruritus , erythema , oedema , abnormal vaginal discharge ) . Clinical finding compatible Chlamydia trachomatis , Neisseria gonorrhoeae Trichomonas vaginalis infection . Use antifungal , antibiotic probiotic medication within last 2 week prior study . Patients receive treatment ( drug , probiotic vitamin supplement ) significantly interfere study evaluation 3 month followup . Pregnant high risk pregnancy .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>